Dylan Hartley

Insider Reports History

Entity
Individual
Location
C/O Onkure, Inc., 6707 Winchester Circle, Suite 400, Boulder, CO
Signature
/s/ Rogan Nunn, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dylan Hartley:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Reneo Pharmaceuticals, Inc. Chief Scientific Officer Employee Stock Option (right to buy) 138K Oct 4, 2024 Direct

Insider Reports Filed by Dylan Hartley

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 1 $0 4 Oct 8, 2024 Chief Scientific Officer
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 0 $0 3 Oct 8, 2024 Chief Scientific Officer